title: Pseudotumor cerebri: a presenting manifestation of Addison's disease.
authors.affiliation: Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520-8064, USA.
authors.forename: N
authors.initials: N
authors.lastname: Condulis
authors.forename: G
authors.initials: G
authors.lastname: Germain
authors.forename: N
authors.initials: N
authors.lastname: Charest
authors.forename: S
authors.initials: S
authors.lastname: Levy
authors.forename: T O
authors.initials: TO
authors.lastname: Carpenter
mesh_terms: D000224:Addison Disease / Q000150:complications* / Q000188:drug therapy; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001002:Anuria / Q000209:etiology; D002648:Child; D003366:Cosyntropin / Q000008:administration & dosage / Q000627:therapeutic use; D003371:Cough / Q000209:etiology; D004172:Diplopia / Q000209:etiology; D005260:Female; D005438:Fludrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D006261:Headache / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008901:Mineralocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D018908:Muscle Weakness / Q000209:etiology; D011559:Pseudotumor Cerebri / Q000209:etiology*; D013575:Syncope / Q000209:etiology; D014839:Vomiting / Q000209:etiology; D015431:Weight Loss
chemical_list: D000893:Anti-Inflammatory Agents; D008901:Mineralocorticoids; D003366:Cosyntropin; D005438:Fludrocortisone; D006854:Hydrocortisone